ADD ANYTHING HERE OR JUST REMOVE IT…
  • About Us
    • Scientific Advisory
  • Technology
  • Products
  • Clinical Solutions
    • Cardiothoracic Surgery
    • Vascular Surgery
    • Urology Surgery
    • General Surgery
  • Distributor
  • Resources
    • Events
    • News
    • Publications
  • Contact Us
Let's Connect +1 (949) 670 0403
Tisgenx
Menu
  • About Us
    • Scientific Advisory
  • Technology
  • Products
  • Clinical Solutions
    • Cardiothoracic Surgery
    • Vascular Surgery
    • Urology Surgery
    • General Surgery
  • Distributor
  • Resources
    • Events
    • News
    • Publications
  • Contact Us

Monthly Archives: January 2025

Home2025JanuaryPage 4
General

Direct-acting oral anticoagulant removal by intraoperative hemoadsorption in CABG and/or single valve surgery: interim analysis of the International Safe and Timely Antithrombotic Removal (STAR) registry

Posted by author-avatar admin
January 21, 2025
0
Patients on direct-acting oral anticoagulants (DOACs) are at high risk of perioperative bleeding complications. Intraoperative hemoadsorption is a novel strategy to reduce perioperative bleeding in patients on...
Continue reading
General

Electrocoagulation-free strategy in minimally invasive direct coronary artery bypass with hybrid revascularisation – a case report

Posted by author-avatar admin
January 21, 2025
0
Hybrid coronary revascularisation benefits patients with multivessel disease, as it amalgamates the minimally invasive direct coronary artery bypass (MIDCAB) procedure and percutaneous coronary intervention (P...
Continue reading
General

Anti-adhesive Properties of Epoxy-Treated Xenopericardium Modified with Polyvinyl Alcohol: in vitro Study of Leukocyte Adhesion in the Pulsatile Flow Model

Posted by author-avatar admin
January 21, 2025
0
CONCLUSION: The suggested modification of epoxy-treated bovine pericardium with polyvinyl alcohol prevents the adhesion of immune cells to the implant surface and can potentially protect bioprosthetic heart valves from immune rejection.
Continue reading
General

Surgery for chronic pyothorax after failed amplatzer closure of bronchopleural fistula

Posted by author-avatar admin
January 18, 2025
0
Post-pneumonectomy bronchopleural fistula (BPF) is a life-threatening event whose treatment is not standardized.
Continue reading
General

Surgery for chronic pyothorax after failed amplatzer closure of bronchopleural fistula

Posted by author-avatar admin
January 17, 2025
0
Post-pneumonectomy bronchopleural fistula (BPF) is a life-threatening event whose treatment is not standardized.
Continue reading
General

Risk of myocardial infarction and heart failure in gout patients: a systematic review and meta-analysis

Posted by author-avatar admin
January 17, 2025
0
Gout is a metabolic disease caused by decreased blood uric acid excretion and purine metabolism disorders. Long-term and persistent metabolic dysfunction gradually affects other organ functions and is the main...
Continue reading
General

Integrative bioinformatics and machine learning approach unveils potential biomarkers linking coronary atherosclerosis and fatty acid metabolism-associated gene

Posted by author-avatar admin
January 17, 2025
0
Atherosclerosis (AS) is increasingly recognized as a chronic inflammatory disease that significantly compromises vascular health and acts as a major contributor to cardiovascular diseases. Advancements in lipi...
Continue reading
General

Surgery for chronic pyothorax after failed amplatzer closure of bronchopleural fistula

Posted by author-avatar admin
January 16, 2025
0
Post-pneumonectomy bronchopleural fistula (BPF) is a life-threatening event whose treatment is not standardized.
Continue reading
General

Ascending aorta dilatation for pulmonary atresia with ventricular septal defect: a report of three adult cases

Posted by author-avatar admin
January 16, 2025
0
Patients with pulmonary atresia and ventricular septal defect (PA/VSD) are prone to progressive aortic dilation. However, there are relatively few reports of progressive development of aortic aneurysm or aorti...
Continue reading
General

Evidence and perspectives on miRNA, circRNA, and lncRNA in myocardial ischemia-reperfusion injury: a bibliometric study

Posted by author-avatar admin
January 16, 2025
0
miRNA, circRNA, and lncRNA play crucial roles in the pathogenesis and progression of myocardial ischemia-reperfusion injury (MI/RI). This study aims to provide valuable insights into miRNA, circRNA, lncRNA, an...
Continue reading
  • «
  • ‹
  • 2
  • 3
  • 4
  • 5
  • 6
  • ›
  • »
Close

Recent Posts

  • Impact of the COVID-19 pandemic on admission trends, diagnosis patterns, and demographics of ischemic heart disease patients: a retrospective study
  • In Vivo Preclinical Testing of a Bridging Stent for Fenestrated Endovascular Repair Using a Dedicated Swine Pararenal Aneurysm Model
  • Managing the Giant: A Novel Approach in Orthotopic Heart Transplantation With Extreme Left Atrial Enlargement
  • Aortic and mitral valve repair in a child with rheumatic heart disease
  • Impact of the COVID-19 pandemic on admission trends, diagnosis patterns, and demographics of ischemic heart disease patients: a retrospective study

Recent Comments

  1. A WordPress Commenter on Hello world!

Archives

  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022

Categories

  • Uncategorized
  • General
  • Tisgenx

Quick Links

  • About Us
  • Technology
  • Products
  • Distributor
  • Resources

Clinical Solutions

  • Cardiothoracic Surgery
  • Vascular Surgery
  • Urology Surgery
  • General Surgery

Resources

Brand Names

  • Events
  • News
  • Publications
  • Invengenx®
  • Vascugenx®
  • Urogenx®
  • Surgenx™

Contact Info

Address:

15615 Alton Parkway, Suite 450, Irvine, CA 92618

Phone:

+1 (949) 670-0403

Email:

info@tisgenx.com

Copyright © 2025 TisgenX. Privacy Policy. All Rights Reserved.
Close
  • About Us
    • Scientific Advisory
  • Technology
  • Products
  • Clinical Solutions
    • Cardiothoracic Surgery
    • Vascular Surgery
    • Urology Surgery
    • General Surgery
  • Distributor
  • Resources
    • Events
    • News
    • Publications
  • Contact Us
Shop
Sidebar